To include your compound in the COVID-19 Resource Center, submit it here.

Brilinta ticagrelor regulatory update

The U.K.'s NICE issued a preliminary appraisal recommending use of AstraZeneca's Brilique ticagrelor

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE